Eventide Asset Management - Q2 2018 holdings

$2.41 Billion is the total value of Eventide Asset Management's 144 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 20.8% .

 Value Shares↓ Weighting
ASND BuyASCENDIS PHARMA A Ssponsored adr$92,263,000
+5.9%
1,387,000
+4.1%
3.83%
-6.2%
XPO  XPO LOGISTICS INC$78,942,000
-1.6%
788,0000.0%3.28%
-12.8%
W  WAYFAIR INCcl a$74,344,000
+75.9%
626,0000.0%3.08%
+55.9%
SAGE BuySAGE THERAPEUTICS INC$57,916,000
+43.8%
370,000
+48.0%
2.40%
+27.5%
LOW  LOWES COS INC$53,997,000
+8.9%
565,0000.0%2.24%
-3.4%
COLL  COLLEGIUM PHARMACEUTICAL INC$52,651,000
-6.7%
2,207,6100.0%2.18%
-17.3%
SRPT BuySAREPTA THERAPEUTICS INC$49,568,000
+196.0%
375,000
+65.9%
2.06%
+162.4%
SPLK  SPLUNK INC$44,897,000
+0.7%
453,0000.0%1.86%
-10.7%
HUBS  HUBSPOT INC$43,890,000
+15.8%
350,0000.0%1.82%
+2.6%
AIMT BuyAIMMUNE THERAPEUTICS INC$43,562,000
-12.5%
1,620,000
+3.5%
1.81%
-22.5%
BLUE  BLUEBIRD BIO INC$43,570,000
-8.1%
277,6030.0%1.81%
-18.5%
MIC  MACQUARIE INFRASTRUCTURE COR$43,550,000
+14.3%
1,032,0000.0%1.81%
+1.3%
PANW BuyPALO ALTO NETWORKS INC$42,738,000
+126.4%
208,000
+100.0%
1.77%
+100.7%
ABBV  ABBVIE INC$41,415,000
-2.1%
447,0000.0%1.72%
-13.2%
VRTX  VERTEX PHARMACEUTICALS INC$41,300,000
+4.3%
243,0000.0%1.71%
-7.6%
INST  INSTRUCTURE INC$40,082,000
+0.9%
942,0000.0%1.66%
-10.5%
LOXO  LOXO ONCOLOGY INC$39,727,000
+50.4%
229,0000.0%1.65%
+33.3%
LRCX  LAM RESEARCH CORP$39,237,000
-14.9%
227,0000.0%1.63%
-24.6%
WCN  WASTE CONNECTIONS INC$38,920,000
+4.9%
517,0000.0%1.62%
-7.0%
VRNS BuyVARONIS SYS INC$37,960,000
+31.0%
509,528
+6.4%
1.58%
+16.1%
NEP BuyNEXTERA ENERGY PARTNERS LP$37,616,000
+17.3%
806,000
+0.5%
1.56%
+3.9%
SGEN  SEATTLE GENETICS INC$36,979,000
+26.8%
557,0000.0%1.54%
+12.5%
MYOV BuyMYOVANT SCIENCES LTD$36,630,000
+200.3%
1,601,661
+179.3%
1.52%
+166.2%
STKL  SUNOPTA INC$36,125,000
+18.3%
4,300,5400.0%1.50%
+4.8%
MGA SellMAGNA INTL INC$35,721,000
+2.5%
614,500
-0.6%
1.48%
-9.2%
STLD  STEEL DYNAMICS INC$34,646,000
+3.9%
754,0000.0%1.44%
-7.9%
LEA  LEAR CORP$34,189,000
-0.2%
184,0000.0%1.42%
-11.5%
ASML  ASML HOLDING N V$34,051,000
-0.3%
172,0000.0%1.41%
-11.6%
TTD  THE TRADE DESK INC$33,768,000
+89.0%
360,0000.0%1.40%
+67.6%
KAR  KAR AUCTION SVCS INC$33,428,000
+1.1%
610,0000.0%1.39%
-10.4%
CCI  CROWN CASTLE INTL CORP NEW$32,885,000
-1.6%
305,0000.0%1.36%
-12.8%
FIVN  FIVE9 INC$30,906,000
+16.0%
894,0000.0%1.28%
+2.9%
WBC  WABCO HLDGS INC$29,910,000
-12.6%
255,6000.0%1.24%
-22.5%
MGTA NewMAGENTA THERAPEUTICS INC$29,513,0002,238,088
+100.0%
1.22%
CELG  CELGENE CORP$28,671,000
-11.0%
361,0000.0%1.19%
-21.1%
QURE BuyUNIQURE NV$28,503,000
+262.0%
754,050
+125.1%
1.18%
+220.6%
IDTI  INTEGRATED DEVICE TECHNOLOGY$26,333,000
+4.3%
826,0000.0%1.09%
-7.5%
XLRN  ACCELERON PHARMA INC$25,711,000
+24.1%
529,9000.0%1.07%
+10.0%
AVRO NewAVROBIO INC$25,560,000928,891
+100.0%
1.06%
ELLI  ELLIE MAE INC$25,129,000
+12.9%
242,0000.0%1.04%
+0.1%
ROP BuyROPER TECHNOLOGIES INC$24,004,000
+44.9%
87,000
+47.5%
1.00%
+28.5%
APTV BuyAPTIV PLC$23,750,000
+42.2%
259,200
+31.9%
0.99%
+26.1%
LII  LENNOX INTL INC$23,618,000
-2.1%
118,0000.0%0.98%
-13.2%
ARW  ARROW ELECTRS INC$22,208,000
-2.3%
295,0000.0%0.92%
-13.3%
ZGNX BuyZOGENIX INC$21,128,000
+99.1%
478,000
+80.4%
0.88%
+76.5%
JELD BuyJELD-WEN HLDG INC$20,013,000
+1.5%
700,000
+8.7%
0.83%
-10.0%
VCYT  VERACYTE INC$19,927,000
+68.0%
2,133,5000.0%0.83%
+49.0%
PEGI BuyPATTERN ENERGY GROUP INCcl a$19,931,000
+11.4%
1,063,000
+2.8%
0.83%
-1.2%
GTTN  GTT COMMUNICATIONS INC$19,845,000
-20.6%
441,0000.0%0.82%
-29.6%
PFPT  PROOFPOINT INC$18,219,000
+1.5%
158,0000.0%0.76%
-10.1%
IPHI  INPHI CORP$18,099,000
+8.3%
555,0000.0%0.75%
-4.0%
AY BuyATLANTICA YIELD PLC$17,436,000
+7.6%
864,000
+4.4%
0.72%
-4.6%
STML  STEMLINE THERAPEUTICS INC$17,437,000
+4.9%
1,086,4000.0%0.72%
-6.9%
ANET  ARISTA NETWORKS INC$16,994,000
+0.9%
66,0000.0%0.70%
-10.6%
MTD NewMETTLER TOLEDO INTERNATIONAL$16,780,00029,000
+100.0%
0.70%
IMMU NewIMMUNOMEDICS INC$16,545,000699,000
+100.0%
0.69%
NBIX  NEUROCRINE BIOSCIENCES INC$15,325,000
+18.5%
156,0000.0%0.64%
+5.0%
SNA SellSNAP ON INC$15,183,000
-37.4%
94,470
-42.6%
0.63%
-44.5%
AGIO  AGIOS PHARMACEUTICALS INC$14,993,000
+3.0%
178,0000.0%0.62%
-8.8%
MYOK BuyMYOKARDIA INC$14,994,000
+102.1%
302,000
+98.7%
0.62%
+79.3%
HASI BuyHANNON ARMSTRONG SUST INFR C$14,595,000
+3.4%
739,000
+2.1%
0.61%
-8.3%
SLDB  SOLID BIOSCIENCES INC$14,252,000
+375.1%
400,0000.0%0.59%
+322.1%
VMC  VULCAN MATLS CO$14,197,000
+13.0%
110,0000.0%0.59%
+0.2%
CRUS  CIRRUS LOGIC INC$14,182,000
-5.7%
370,0000.0%0.59%
-16.3%
VYGR  VOYAGER THERAPEUTICS INC$13,745,000
+4.0%
703,4250.0%0.57%
-7.9%
MDGL BuyMADRIGAL PHARMACEUTICALS INC$12,866,000
+340.6%
46,000
+84.0%
0.53%
+289.8%
WVE SellWAVE LIFE SCIENCES LTD$12,485,000
-17.6%
326,400
-13.7%
0.52%
-27.0%
DOOR  MASONITE INTL CORP NEW$12,215,000
+17.1%
170,0000.0%0.51%
+3.9%
BOLD BuyAUDENTES THERAPEUTICS INC$10,508,000
+29.5%
275,000
+1.9%
0.44%
+14.7%
BHVN SellBIOHAVEN PHARMACTL HLDG CO L$10,038,000
+12.6%
254,000
-26.6%
0.42%0.0%
BPMC  BLUEPRINT MEDICINES CORP$9,522,000
-30.8%
150,0000.0%0.40%
-38.7%
PAYC  PAYCOM SOFTWARE INC$9,488,000
-8.0%
96,0000.0%0.39%
-18.4%
MNTA BuyMOMENTA PHARMACEUTICALS INC$9,080,000
+25.1%
444,000
+11.0%
0.38%
+10.9%
IFRX  INFLARX NV$8,869,000
+11.8%
275,0000.0%0.37%
-0.8%
GWPH  GW PHARMACEUTICALS PLCads$8,861,000
+23.8%
63,5000.0%0.37%
+9.9%
XNCR  XENCOR INC$8,438,000
+23.5%
228,0000.0%0.35%
+9.4%
ARGX  ARGENX SEsponsored adr$8,286,000
+3.0%
100,0000.0%0.34%
-8.8%
EXR SellEXTRA SPACE STORAGE INC$7,985,000
+10.1%
80,000
-3.6%
0.33%
-2.4%
REGN  REGENERON PHARMACEUTICALS$7,935,000
+0.2%
23,0000.0%0.33%
-11.3%
EXAS  EXACT SCIENCES CORP$7,832,000
+48.2%
131,0000.0%0.32%
+31.6%
SUPN  SUPERNUS PHARMACEUTICALS INC$7,781,000
+30.7%
130,0000.0%0.32%
+15.8%
RCKT  ROCKET PHARMACEUTICALS INC$7,746,000
+4.7%
394,5850.0%0.32%
-7.2%
FENC  FENNEC PHARMACEUTICALS INC$7,738,000
-13.6%
741,1750.0%0.32%
-23.6%
INCY BuyINCYTE CORP$7,705,000
+198.3%
115,000
+271.0%
0.32%
+164.5%
KALV  KALVISTA PHARMACEUTICALS INC$7,308,000
-14.3%
900,0000.0%0.30%
-24.1%
BMRN  BIOMARIN PHARMACEUTICAL INC$7,065,000
+16.2%
75,0000.0%0.29%
+2.8%
RARE  ULTRAGENYX PHARMACEUTICAL IN$6,718,000
+50.7%
87,4000.0%0.28%
+33.5%
CERN  CERNER CORP$6,469,000
+3.1%
108,2000.0%0.27%
-8.8%
ALNY  ALNYLAM PHARMACEUTICALS INC$6,106,000
-17.3%
62,0000.0%0.25%
-26.9%
RGEN  REPLIGEN CORP$5,174,000
+30.0%
110,0000.0%0.22%
+15.6%
KNSA NewKINIKSA PHARMACEUTICALS LTD$5,143,000296,400
+100.0%
0.21%
ANAB NewANAPTYSBIO INC$5,115,00072,000
+100.0%
0.21%
VBIV  VBI VACCINES INC$5,088,000
-21.4%
1,850,0000.0%0.21%
-30.4%
ECYT  ENDOCYTE INC$4,830,000
+51.8%
350,0000.0%0.20%
+34.2%
SNSS  SUNESIS PHARMACEUTICALS INC$4,803,000
-22.1%
2,265,4550.0%0.20%
-30.9%
RARX  RA PHARMACEUTICALS INC$3,861,000
+87.4%
388,0000.0%0.16%
+66.7%
GLPG  GALAPAGOS NVspon adr$3,687,000
-7.6%
40,0000.0%0.15%
-18.2%
IRWD  IRONWOOD PHARMACEUTICALS INC$3,671,000
+23.9%
192,0000.0%0.15%
+9.4%
IOVA NewIOVANCE BIOTHERAPEUTICS INC$3,584,000280,000
+100.0%
0.15%
EIDX NewEIDOS THERAPEUTICS INC$3,295,000162,000
+100.0%
0.14%
DBVT  DBV TECHNOLOGIES S Asponsored adr$3,279,000
-16.4%
170,0000.0%0.14%
-26.1%
DERM  DERMIRA INC$3,073,000
+15.1%
334,0000.0%0.13%
+2.4%
BEP BuyBROOKFIELD RENEWABLE PARTNERpartnership unit$3,065,000
-0.6%
102,000
+3.0%
0.13%
-11.8%
MGNX  MACROGENICS INC$3,036,000
-17.9%
147,0000.0%0.13%
-27.2%
CBIO NewCATALYST BIOSCIENCES INC$2,871,000246,000
+100.0%
0.12%
FHB BuyFIRST HAWAIIAN INC$2,684,000
+9.0%
92,500
+4.5%
0.11%
-3.5%
ABB BuyABB LTDsponsored adr$2,406,000
+6.7%
110,500
+16.3%
0.10%
-5.7%
DLPH  DELPHI TECHNOLOGIES PLC$2,394,000
-4.6%
52,6660.0%0.10%
-16.1%
PTCT  PTC THERAPEUTICS INC$2,300,000
+24.7%
68,2000.0%0.10%
+10.5%
JCI BuyJOHNSON CTLS INTL PLC$2,258,000
-3.6%
67,500
+1.5%
0.09%
-14.5%
HMC BuyHONDA MOTOR LTD$2,225,000
+8.6%
76,000
+28.8%
0.09%
-4.2%
TSM BuyTAIWAN SEMICONDUCTOR MFG LTDsponsored adr$2,175,000
+19.8%
59,500
+43.4%
0.09%
+5.9%
SEP BuySPECTRA ENERGY PARTNERS LP$2,125,000
+14.9%
60,000
+9.1%
0.09%
+1.1%
BG BuyBUNGE LIMITED$1,917,000
+19.5%
27,500
+26.7%
0.08%
+6.7%
BDN BuyBRANDYWINE RLTY TRsh ben int new$1,933,000
+17.6%
114,500
+10.6%
0.08%
+3.9%
EPIX NewESSA PHARMA INC$1,822,000481,971
+100.0%
0.08%
ETN BuyEATON CORP PLC$1,831,000
+34.8%
24,500
+44.1%
0.08%
+18.8%
ACAD  ACADIA PHARMACEUTICALS INC$1,735,000
-32.0%
113,6000.0%0.07%
-40.0%
SYRS  SYROS PHARMACEUTICALS INC$1,532,000
-21.3%
150,0000.0%0.06%
-29.7%
MLHR BuyMILLER HERMAN INC$1,492,000
+14.4%
44,000
+7.8%
0.06%
+1.6%
GPMT BuyGRANITE PT MTG TR INC$1,505,000
+63.9%
82,000
+47.7%
0.06%
+44.2%
CCIPRA BuyCROWN CASTLE INTL CORP NEW6.875% con pfd a$1,443,000
+29.4%
1,355
+36.9%
0.06%
+15.4%
TERP SellTERRAFORM PWR INC$1,445,000
-16.4%
123,500
-23.3%
0.06%
-25.9%
APU  AMERIGAS PARTNERS L Punit l p int$1,351,000
+5.6%
32,0000.0%0.06%
-6.7%
CVA BuyCOVANTA HLDG CORP$1,295,000
+21.5%
78,500
+6.8%
0.05%
+8.0%
BuyHANNON ARMSTRONG SUST INFR Cnote 4.125% 9/0$1,287,000
+7.4%
1,337,000
+7.0%
0.05%
-5.4%
VTR BuyVENTAS INC$1,224,000
+26.7%
21,500
+10.3%
0.05%
+13.3%
ARE NewALEXANDRIA REAL ESTATE EQ IN$1,199,0009,500
+100.0%
0.05%
TSRO  TESARO INC$1,156,000
-22.2%
26,0000.0%0.05%
-31.4%
WELL  WELLTOWER INC$1,103,000
+15.1%
17,6000.0%0.05%
+2.2%
NYLD  NRG YIELD INCcl c$1,049,000
+1.2%
61,0000.0%0.04%
-10.2%
PLD NewPROLOGIS INC$985,00015,000
+100.0%
0.04%
ERIC BuyERICSSONadr b sek 10$940,000
+27.7%
122,500
+6.5%
0.04%
+14.7%
AYI BuyACUITY BRANDS INC$794,000
+40.8%
6,850
+69.1%
0.03%
+26.9%
CIG BuyCOMPANHIA ENERGETICA DE MINAsp adr n-v pfd$800,000
-7.4%
435,000
+29.9%
0.03%
-17.5%
LPT BuyLIBERTY PPTY TRsh ben int$776,000
+26.0%
17,500
+12.9%
0.03%
+10.3%
LXP  LEXINGTON REALTY TRUST$698,000
+10.8%
80,0000.0%0.03%0.0%
IR NewINGERSOLL-RAND PLC$664,0007,400
+100.0%
0.03%
PSA NewPUBLIC STORAGE$454,0002,000
+100.0%
0.02%
EIGR SellEIGER BIOPHARMACEUTICALS INC$439,000
-29.3%
36,000
-42.9%
0.02%
-37.9%
NewDERMIRA INCnote 3.000% 5/1$413,000500,000
+100.0%
0.02%
 ACORDA THERAPEUTICS INCnote 1.750% 6/1$389,000
+6.3%
400,0000.0%0.02%
-5.9%
VICL SellVICAL INC$345,000
-86.0%
300,000
-82.4%
0.01%
-87.8%
 HERCULES CAPITAL INCdbcv 4.375% 2/0$200,000
-1.5%
200,0000.0%0.01%
-20.0%
WBK ExitWESTPAC BKG CORPsponsored adr$0-40,000
-100.0%
-0.04%
MNLO ExitMENLO THERAPEUTICS INC$0-25,000
-100.0%
-0.04%
TNDM ExitTANDEM DIABETES CARE INC$0-275,000
-100.0%
-0.06%
PRTA ExitPROTHENA CORP PLC$0-37,000
-100.0%
-0.06%
FPRX ExitFIVE PRIME THERAPEUTICS INC$0-105,000
-100.0%
-0.08%
ExitESSA PHARMA INC$0-9,639,410
-100.0%
-0.09%
ACRS ExitACLARIS THERAPEUTICS INC$0-140,000
-100.0%
-0.12%
AQXP ExitAQUINOX PHARMACEUTICALS INC$0-175,000
-100.0%
-0.12%
AKCA ExitAKCEA THERAPEUTICS INC$0-175,000
-100.0%
-0.21%
ATHN ExitATHENAHEALTH INC$0-37,000
-100.0%
-0.25%
TSLA ExitTESLA INC$0-30,000
-100.0%
-0.37%
TWLO ExitTWILIO INCcl a$0-327,000
-100.0%
-0.58%
ONCE ExitSPARK THERAPEUTICS INC$0-270,000
-100.0%
-0.84%
CAFD Exit8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt$0-1,553,600
-100.0%
-0.88%
AVXS ExitAVEXIS INC$0-421,000
-100.0%
-2.44%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-08-14
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC40Q3 20233.2%
PALO ALTO NETWORKS INC40Q3 20233.6%
ASML HOLDINGS NV40Q3 20231.9%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
REPLIGEN CORP40Q3 20230.5%
VERACYTE INC38Q3 20231.5%
LAM RESEARCH CORP35Q3 20233.4%
XPO LOGISTICS INC34Q1 20233.8%
COLLEGIUM PHARMACEUTICAL INC34Q3 20232.6%
MAGNA INTL INC33Q4 20212.5%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q2 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cogent Biosciences, Inc.February 14, 20232,589,7783.7%
ESSA Pharma Inc.Sold outFebruary 14, 202300.0%
Freeline Therapeutics Holdings plcFebruary 14, 20235,920,7659.1%
KnowBe4, Inc.Sold outFebruary 14, 202300.0%
Praxis Precision Medicines, Inc.February 14, 20233,518,0627.5%
Prometheus Biosciences, Inc.February 14, 20231,032,9382.2%
SUTRO BIOPHARMA, INC.Sold outFebruary 14, 202300.0%
Vital Farms, Inc.Sold outFebruary 14, 202300.0%
Zymeworks Inc.Sold outFebruary 14, 202300.0%
Entasis Therapeutics Holdings Inc.February 14, 2022590,6021.2%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings